Abstract
The potential roles of fluorodeoxyglucose positron emission tomography/computed tomography imaging in ovarian cancer include noninvasive characterization of an ovarian mass, staging, and treatment planning. This article assesses these roles for predicting and monitoring response to treatment, restaging, and early diagnosis of recurrence.
Original language | English |
---|---|
Pages (from-to) | 447-461 |
Number of pages | 15 |
Journal | PET Clinics |
Volume | 5 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2010 |
Keywords
- Computed tomography
- Fluorodeoxyglucose
- Ovarian cancer
- PET